Sanofi Genzyme Recognizes Rare Disease Advocacy Organizations Across the Globe:
2019 PAL Award Grant Recipients
This year, five recipients were chosen from a diverse group of 32 global candidates who submitted compelling proposals supporting the LSD patient community. After careful consideration, an independent external review committee selected the winning recipients from Romania, Australia/New Zealand, France, Italy and India.
“Each year, the recipients of the PAL Award Grant support different needs facing the lysosomal storage disorder patient community,” said Sebastien Martel, Global Head of Rare Diseases. “Their work is critical to raising awareness, optimizing care and meeting the ever-growing needs of those living with rare diseases across globe.”
Since the program’s inception, Sanofi Genzyme has awarded more than $900,000 to support 57 projects, including patient workshops, advocacy trainings, awareness campaigns and research, proposed by organizations across 28 countries.
We are proud to announce the 2019 PAL Award recipients:
The next PAL awards submission period is expected to open in early 2020.